Suppr超能文献

钙内流阻断对运动犬左心室动力学的影响。

Effects of calcium entry blockade on left ventricular dynamics in exercising dogs.

作者信息

Walsh R A, Cleary F X, O'Rourke R A

出版信息

Am J Physiol. 1986 Sep;251(3 Pt 2):H656-63. doi: 10.1152/ajpheart.1986.251.3.H656.

Abstract

To study the previously undefined effects of calcium entry blockade on left ventricular (LV) function and coronary blood flow during dynamic exercise we gave intravenous equihypotensive infusions of nifedipine (10 +/- 4 SE micrograms X kg-1 X min-1), diltiazem (60 +/- 8 micrograms X kg-1 X min-1), and verapamil (52 +/- 7 micrograms X kg-1 X min-1) before and after intravenous propranolol (2 mg/kg) to chronically instrumented dogs at rest and while running on a treadmill at 4 and 10 km/h. Prior to beta-blockade, each agent significantly and equivalently (P = NS among drugs) reduced mean arterial pressure during exercise (-13% nifedipine, -8% diltiazem, -15% verapamil at 4 km/h, each P less than or equal to 0.01 vs. exercise alone) but did not significantly alter LV end-diastolic dimension (EDD), heart rate, or cardiac output compared with exercise alone. Only verapamil blunted the positive inotropic response to exercise (LV dP/dtmax decreased 20% at 4 km/h, P less than 0.01 vs. exercise alone). Coronary blood flow was significantly and equivalently increased at rest and during submaximal exercise with each calcium blocker, but this effect was largely offset by propranolol. During exercise after beta-blockade each agent produced significant additional reductions in mean arterial pressure and dP/dtmax at peak exercise but did not alter LVEDD or heart rate compared with results obtained with propranolol alone. Combined beta-blockade and verapamil uniquely diminished myocardial contractility to a greater extent at peak exercise than at rest (dP/dtmax 1,260 +/- 410 peak exercise vs. 1,775 +/- 431 mmHg/s rest, P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为研究钙通道阻滞剂对动态运动期间左心室(LV)功能和冠状动脉血流量的此前未明确的影响,我们在静息状态以及在跑步机上以4公里/小时和10公里/小时速度奔跑时,对长期植入仪器的犬静脉注射普萘洛尔(2毫克/千克)前后,分别静脉输注等效降压剂量的硝苯地平(10±4微克·千克⁻¹·分钟⁻¹)、地尔硫䓬(60±8微克·千克⁻¹·分钟⁻¹)和维拉帕米(52±7微克·千克⁻¹·分钟⁻¹)。在β受体阻滞剂给药前,每种药物在运动期间均显著且等效地降低平均动脉压(4公里/小时时,硝苯地平降低13%,地尔硫䓬降低8%,维拉帕米降低15%,每种药物与单独运动相比,P均≤0.01),但与单独运动相比,未显著改变左心室舒张末期内径(EDD)、心率或心输出量。只有维拉帕米减弱了运动时的正性肌力反应(4公里/小时时左心室dP/dtmax降低20%,与单独运动相比,P<0.01)。在静息和次极量运动期间,每种钙通道阻滞剂均显著且等效地增加冠状动脉血流量,但这种作用在很大程度上被普萘洛尔抵消。在β受体阻滞剂给药后的运动期间,每种药物在运动峰值时均使平均动脉压和dP/dtmax进一步显著降低,但与单独使用普萘洛尔的结果相比,未改变左心室舒张末期内径或心率。联合使用β受体阻滞剂和维拉帕米在运动峰值时比静息时更独特地更大程度地降低心肌收缩力(运动峰值时dP/dtmax为1260±410,静息时为1775±431毫米汞柱/秒,P<0.001)。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验